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ABSTRACT 
Young, A.B., and D. Chu : Distribution of GABA, and GABA, receptors in mammalian 
brain: potential targets for drug development. Drug Dev. Res. 21 :161-167, 1990. 
GABA is the major inhibitory neurotransmitter in mammalian brain. GABA receptors and 
the metabolism of GABA are significant targets for new centrally acting drugs to treat 
neurological and behavioral disorders. The simple neutral amino acid is likely to subserve 
a neurotransmitter role at 25-50% of all synapses in the central nervous system. GABA's 
actions are mediated by two different receptors, GABA, and GABA, receptors. GABAA 
receptors are ligand-gated chloride channels that are sensitive to the convulsant alkaloid 
bicuculline and modulated by benzodiazepines and barbiturates. GABA, receptors affect 
calcium and potassium conductance through GTP binding proteins and are insensitive to 
bicuculline and sensitive to the agonist baclofen. Both receptors are widely distributed in 
cerebral cortex, hippocampus, basal ganglia, thalamus, cerebellum, and brainstem. 
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INTRODUCTION 
GABA (gamma-aminobutyric acid) is a neutral amino acid that subserves neurotrans- 
mitter functions at an estimated 25-50% of synapses in the mammalian central nervous 
system. GABA is present in brain in concentrations of 1-10 mM. The amino acid is synthe- 
sized from glutamate by the neuronal cytoplasmic enzyme glutamate decarboxylase and it is 
metabolized by mitochondria1 enzymes to alpha-ketoglutwate that enters the Kreb's cycle. The 
synthetic and metabolic enzymes have been purified and antibodies raised against them. The 
enzymes have been localized in rat and human brain by using immunocytochemistry and the 
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GABAergic pathways have been mapped by using this approach [Fagg and Foster, 1983; 
Ribak et al.. 19791. 
In the nerve terminal, GABA is stored in vesicles by a unique sodium-independent, 
ATP-dependent transport system that is selective for GABAergic neurons [Fykse and Fonnum, 
1988; Hell et al., 19881. This uptake system is biochemically and pharmacologically distinct 
from the neuronal and glial membrane high-affinity transport system and is driven by an 
electrochemical proton gradient [Wood and Sidhu, 1986; Debler and Lajtha, 1987; Krogs- 
gaard-Larsen et al., 1987; Larsson et al., 19881. GABA in vesicles and, perhaps, in the 
cytoplasm is released into the synaptic cleft upon depolarization of the terminal by a calcium- 
dependent mechanism. After release, GABA diffuses across the synaptic cleft to interact with 
postsynaptic GABA receptors. GABA is inactivated by diffusion and by a high-affinity , 
sodium-dependent transport system into synaptic terminals and glial cells. The biochemical 
and pharmacological properties of this transport system have been studied in detail and will be 
reviewed in other articles in this volume. 
GABA interacts with two receptor types, so-called GABA, and GABA, receptors 
[Stephenson, 1988; Bowery et al., 1988; Bormann, 19881. GABAA receptors are ligand-gated 
chloride channels that are modulated by benzodiazepines and barbiturates and inhibited by the 
convulsant alkaloid, bicuculline. GABA, receptors are insensitive to bicuculline and are 
sensitive to the agonist baclofen. In this chapter, the distribution of GABA, and GABA, 
receptors in normal rat and human brain will be reviewed. 
MATERIALS AND METHODS 
Male Sprague-Dawley rat brains and coronal sections of human brain from persons 
who died without neurological disease were stored in sealed containers until assay. Tissues 
were mounted onto cryotome pedestals with embedding matrix (Lipshaw) and were allowed 
to equilibrate in the cryostat at -20°C [Chu et al., 1990, 1987b, 1987al. Serial brain sec- 
tions (20 p m  thick, in horizontal or coronal plane) were cut on a Lipshaw cryotome at 
-20°C to - 15°C and thaw mounted onto chrome-alum gelatin-coated slides. Prior to assay, 
sections were prewashed for 15 min in 50 mM Tris-HC1 buffer containing 2.5 mM CaCl, (pH 
7.40) at 4°C. Slides were then removed from the buffer and dried under a stream of 
cool air. 
L3H]GABA was used to examine both GABA, and GABA, receptors. GABA, recep- 
tors were assayed by incubating sections for 45 min at 4°C with ['HIGABA (20-25 nM) in 50 
mM Tris-HC1 buffer (pH 7.4), 2.5 mM CaCl,, and 10 p M  isoguvacine (a GABA, agonist 
which specifically blocks ['HIGABA binding to GABA, receptors). Nonspecific binding was 
determined in the presence of 100 p M  (+-)baclofen. GABA, receptors were assayed by 
incubating sections for 45 min at 4°C with ['HIGABA (20-25 nM) in 50 mM Tris-HC1 buffer 
(pH 7.4), 2.5 mM CaCl,, and 100 p M  (*)badofen (which blocks specifically binding to 
GABA, receptors). Nonspecific binding was determined in the presence of 100 p M  isogu- 
vacine. 
After incubation, slides were individually removed, subjected to three rapid squirts with 
buffer followed by one quick rinse with 2.5% glutaraldehyde in acetone and immediately 
blown dry with warm air. This rinse and dry procedure was completed within 15 sec. The 
slides were mounted in x-ray cassettes and apposed to sheets of tritium-sensitive Ultrafilm 'H 
(LKB) for 3 weeks at 4°C. The films were developed in Kodak D19 for 3 min at 25"C, fixed, 
and dried. Autoradiograms were analyzed by computer-assisted densitometry . Twenty to 25 
readings from each region of interest on each section were averaged. Optical densities were 
quantified in pmol ['HJGABA bound per mg protein by comparing film densities of brain with 
those generated by I4C-embedded plastic standards previously calibrated against brain paste 
standards containing known amounts of tritium and protein. 
GABA, and GABA, Receptors in Mammalian Brain 163 
TABLE 1. Comparison of B,,, and K, Values for GABA, and GABA, Receptors in Various 
Regions of Rat and Human Brain* 
B,,, (pmol GABA boundimg protein) 
Rat brain area GABA, GABA, 
Cerebral cortex 
Layers 1-111 4.02 t 0.26 3.53 t 0.26 
Layer IV 4.69 t 0.22 1.87 t 0.24 
Neostriatum 1.36 t 0.11 0.91 t 0.12 
Dentate gyrus 
Molecular layer 3.97 t 0.13 2.97 t 0.51 
Cerebellum 
Molecular layer 2.64 t 0.18 3.58 t 0.49 
Granular layer 9.30 t 0.38 1.66 t 1.65 
K, (nM) 
Cerebral cortex 
Layers 1-111 92 t 10 341 t 41 
Layer IV 100 ? 19 222 t 46 
Neostriatum 70 t 14 313 ? 58 
Dentate gyrus 
Molecular layer 139 t 15 462 t 54 
Cerebellum 
Molecular layer 164 t 26 481 t 35 
Granular layer 119 * 17 458 t 193 
B, (pmol GABA boundimg protein) 
Human brain area GABA, GABA, 
Cerebral cortex 
Layers 11-111 3.17 t 0.33 1.26 t 0.08 
Layer V 2.36 t 0.31 1.08 t 0.12 
Hippocampus 
Stratum moleculare dentate gyrus 3.51 t 0.69 1.09 t 0.15 
Stratum lacunosum-moleculare of CA1 2.33 t 0.21 0.85 t 0.10 
Stratum pyramidale of CA 3.50 t 0.42 1.04 t 0.14 
Subiculum 1.99 t 0.23 0.55 t 0.17 
K, (nM) 
Cerebral cortex 
Layers 11-111 121 t 30 443 k 139 
Layer V 136 t 33 401 t 79 
Stratum moleculare dentate gyms 234 ? 84 414 i 113 
Stratum lacunosum-moleculare of CAI 167 ? 30 318 t 74 
Subiculum 191 i 46 261 t 85 
*Values represent mean 2 S.E.M. of four brains 
Hippocampus 
Stratum pyramidale of CA 192 t_ 45 355 t 99 
RESULTS 
The affinity of GABA for rat and human GABA, receptors varied between 70 and 170 
nM between regions whereas its affinity for GABA, receptors was 220-480 nM and Hill- 
numbers for the two binding sites were very close to unity in all regions [Chu et al., 1990, 
1987b, 1987al (Table 1). Both receptor subtypes were widely distributed in mammalian brain 
but the relative densities of the two varied from region to region (Figs. 1,2). In olfactory bulb, 
GABA, binding was highest in the glomerular layers, whereas GABA, binding was most 
164 Young and Chu 
Fig. 1. 
concentration was 24 nM (magnification: X 7.25). 
GABA, (left) and GABA, (right) receptors in horizontal hemisections of rat brain. ['HIGABA 
dense in the external plexiform and inner granular layers. GABA receptor binding was dense 
for both subtypes of receptor in cerebral cortex although GABA, receptors were localized in 
distinct cortical layers (dense in layer I-IV) whereas GABA, binding was more diffusely 
distributed through cortex. 
In most areas, GABA, receptors outnumbered GABA, receptors [Chu et al., 19901. 
The exceptions were the medial habenula, the glornerular layer of the olfactory bulb, the 
superficial gray of the superior colliculus, the interpeduncular nucleus, the pontine nuclei, and 
the molecular layer of cerebellum where GABA, receptors were high and GABA, receptors 
were relatively low. 
GABA, and GABA, Receptors in Mammalian Brain 165 
Fig. 2. GABA, (above) and GABA, (below) receptors in human hippocampus. [3H]GABA concen- 
tration was 20 nM. The person died of nonneurological disease and was not on centrally active medica- 
tions at the time of death (magnification: X 10). 
In human hippocampus, GABA, receptors outnumber GABA, receptors approximately 
three or four to one [Chu et al., 1987al. The ratio of the two are fairly constant throughout the 
various hippocampal regions. The two receptor subtypes were most dense in stratum molec- 
ulare of dentate gyrus and stratum pyramidale of CAI and less dense in stratum lacunosum- 
moleculare of CAI and subiculum. 
DISCUSSION 
GABA, and GABA, receptors were widely distributed in mammalian brain and are in 
high concentration in cortical, hippocampal, thalamic, basal ganglia, and cerebellar structures 
[Chu et al., 1990, 1987b,a; Wamsley et al., 1986; McCabe and Wamsley, 1986; Zezula et al., 
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19881. Drugs mediating actions at GABAergic synapses are likely to affect GABAergic 
function in multiple brain areas. 
In recent years, the GABAA receptor has been purified and studied at the molecular level 
[Stephenson, 1988; Schofield et al., 1987; Barnard et al., 1987; Blair et al., 1988; Levitan et 
al., 19881. Several subunits exist for the GABAA receptor and different isoforms of the various 
subunits have also been identified. The different subunits have unique pharmacological and 
electrophysiological properties. Antibodies against the receptor subunits have been used to 
map receptor localization [Houser et al., 1988; De Blas et al., 19881. The various subunits are 
differentially distributed in brain [Wisden et al., 19881. In the future, it may prove possible to 
design drugs that act on specific subpopulations of GABAA receptors. 
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